
Neochem Bio Solutions IPO Subscription Day 1
Posted by : sachet | Tue Dec 02 2025

Here, Neochem Bio Solutions IPO launched on 2nd December 2025. Bidding for the issue will close today, 4th December 2025. The primary aim of the Neochem Bio Solutions IPO is to raise ₹44.97 crores from the market. Also, the Neochem Bio Solutions IPO has received an impressive level of subscription, indicating that the shares will be listed at an impeccable premium. Scroll down to check the Neochem Bio Solutions IPO subscription and details.
Neochem Bio Solutions IPO Details
| IPO Open Date | 2nd December 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹93 to ₹98 per share |
| Lot Size | 1,200 shares |
| Issue Type | Bookbuilding Issue |
| Listing At | NSE & SME |
| IPO Close Date | 2nd December 2025 |
| Listing Date | 9th December 2025 |
The price band for Neochem Bio Solutions’s IPO has been set at Rs 93 to Rs 98, and a total of 45,88,800 shares are being issued. Let’s segregate the share quota fixed for different categories of investors.
| Categories | Shares Offered | % of shares Offered |
| Market Maker Shares Offered | 2,32,800 | 5.07% |
| Qualified Institutional Investors | 21,74,400 | 47.38% |
| Non-Institutional Investors | 6,55,200 | 14.28% |
| Retail Investors | 15,26,400 | 33.26% |
| Total Shares Offered | 45,88,800 | 100.00% |
Neochem Bio Solutions IPO Subscription Status
As of now, the Neochem Bio Solutions IPO has been subscribed 0.32 times. Of these, 0.21 times are subscribed by retail investors, 0.24 times by non-institutional investors, and 0.59 times by QII (Qualified Institutional Investors).
The healthy subscription status indicates that investors are expecting higher returns at the time of Neochem Bio Solutions’ IPO listing on 9th December 2025. Neochem Bio Solutions also has a positive outlook behind the fresh issue of 46,00,000 shares, which will raise around Rs 44.97 crores.
Neochem Bio Solutions IPO GMP Today

We know that higher subscription levels drive grey-market premiums for IPOs. Let’s explore the Neochem Bio Solutions IPO GMP for 2nd December 2025.
The grey market premium for this IPO has surged to 0.00% or Rs 0 per share. It indicates that the estimated listing price per share is Rs 98. Numerous factors played a pivotal role in this jump in the GMP of Neochem Bio Solutions’s IPO. These include higher subscription rates, favourable market sentiment, and investors’ positive attitude towards IPOs.
| GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Listing Gains |
| 2-12-2025 | ₹98.00 | ₹0.00 | ₹98.00 | 0.00% |
| 1-12-2025 | ₹98.00 | ₹5.00 | ₹98.00 | 0.00% |
| 30-11-2025 | ₹98.00 | ₹9.00 | ₹107.00 | 9.18% |
| 29-11-2025 | ₹98.00 | ₹9.00 | ₹107.00 | 9.18% |
| 28-11-2025 | ₹98.00 | ₹6.00 | ₹104.00 | 6.12% |
| 27-11-2025 | ₹98.00 | ₹6.00 | ₹104.00 | 6.12% |
| 26-11-2025 | ₹98.00 | ₹10.00 | ₹108.00 | 10.20% |
| 25-11-2025 | ₹98.00 | ₹0.00 | ₹98.00 | 0.00% |
| 24-11-2025 | ₹98.00 | ₹0.00 | ₹98.00 | 0.00% |
About Neochem Bio Solutions Ltd.
Niochem Bio Solutions was established in 2006 and manufactures speciality performance chemicals. The company’s products are essential and used in industries such as textile & garment washing, home & personal care (HPC), institutional and industrial cleaners, water treatment, paints and coatings, paper and pulp, construction, rubber and dyes and pigments. The company offers a comprehensive range of textile and garment washing auxiliaries, including pre-treatment, dyeing, finishing, printing, and coating applications, for all fabric and garment substrates and is compatible with various processing machines.
- Strengthening the presence across end-user application industries
- Commitment to continuous development of innovative performance chemistries and sustainable solutions
- Continued focus on the expansion of geographical presence
- Leverage existing strategic collaborations and partnerships to diversify end user industries
Neochem Bio Solutions Limited Financials
The company’s financial analysis is essential before applying for the Neochem Bio Solutions IPO. Look at the table to learn about Neochem Bio Solutions Limited’s financials.
| Year Ended | 30th September 2025 (in cr.) | 31st March 2025 (in cr.) | 31st March 2024 (in cr.) | 31st March 2023 (in cr.) |
| Assets | 96.49 | 78.89 | 64.06 | 50.60 |
| Revenue | 47.18 | 86.15 | 62.01 | 48.79 |
| Profit After Tax | 5.48 | 7.75 | 1.80 | 1.07 |
| EBITDA | 8.59 | 13.11 | 5.99 | 4.23 |
| Net Worth | 32.24 | 19.75 | 12.00 | 8.05 |
| Reserves and Surplus | 19.70 | 13.08 | 5.33 | 2.63 |
| Total Borrowings | 38.54 | 35.62 | 33.32 | 26.24 |
Explanation
Neochem Bio Solutions Limited’s revenue soared by 39% from ₹62.01 crores in March 2024 to ₹86.15 crores in March 2025. Moreover, the company’s PAT increased by 330% from ₹1.80 crores in March 2024 to ₹7.75 crores in March 2025.
Technical Indicators
A number of technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Neochem Bio Solutions IPO.
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 15.85 |
| EPS (Earnings Per Share) | 6.18 |
| RoNW | 48.82% |
| ROCE | 41.67% |
| ROE | 48.82% |
| EBITDA Margin | 15.58% |
| Price to Book Value | 5.80 |
| Market Capitalisation | ₹167.78 |
Neochem Bio Solutions IPO Listing Expectations
Neochem Bio Solutions IPO Highlights: IPO allotment is still pending, as the bid will close today. However, given the current GMP or market sentiment, it is reasonable to expect higher listing gains for the share. A jump of 0.00% in Yash Highlight GMP suggests the estimated listing price per share will be around Rs 98.
It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts’ top long-term recommendation.
Neochem Bio Solutions IPO Dates
| IPO Open Date | 5th December 2025 |
| IPO Close Date | 2nd December 2025 |
| Allotment | 4th December 2025 |
| Refund Date | 8th December 2025 |
| IPO Listing Date | 9th December 2025 |
Note: It is to be noted that IPO GMP is volatile based on market sentiment. Hence, one should conduct their research before investing in it.
Recent Articles
Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates
Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates
Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?
Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY
Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Neochem Bio Solutions IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Mahendra Realtors IPO GMP & Review: Apply or Avoid?
Regaal Resources IPO GMP & Review: Apply or Avoid?
Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?

